Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL831P (RNA, 7SL, cytoplasmic 831, pseudogene) is a pseudogene in the human genome[1][6][4]. It is categorized as a 7SL RNA-related pseudogene, part of a large group of genetic elements derived from the RNA component of the signal recognition particle (SRP)[5][3]. Unlike functional genes, pseudogenes like RN7SL831P do not encode functional products and generally lack biological activity[4]. While some 7SL pseudogenes can be transcribed at low levels, there is no evidence suggesting RN7SL831P produces a functional RNA or protein, nor does it have a therapeutic, receptor, or enzyme role[1][6][4][5]. It is not considered a therapeutic target, and there is no known role in disease, drug interaction, or actionable biomarker status. The inclusion of the pseudogene in target panels is generally considered an error for therapeutic or drug discovery purposes due to its lack of biological function[4][6][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 831, pseudogene (RN7SL831P).